-
The use of deep brain stimulation (DBS) in the treatment of Parkinson's disease and other neurological disorders has been the subject of many research studies and has been approved by the Food and Drug Administration since 1997.
-
As bioethicists and other experts in human subjects research protection take a closer look at the IRB's role, two interesting questions emerge: First, how can IRBs improve their risk-benefit analyses of trials, and, secondly, should IRBs even be in the business of making risk-benefit determinations?
-
In an effort to address the wide variance in state laws and policies regarding the research use of newborn screening blood spots, a federal advisory committee is considering a proposal for a national policy.
-
More than 75% of parents surveyed in a nationwide study would be willing to allow their children's newborn screening samples to be used for future research if researchers first asked their permission.
-
An Austin, TX, orthopedic surgeon has agreed that he and his staff will not deny or withhold medically appropriate treatment from patients solely because they are HIV-positive, according to the Department of Health and Human Services (HHS).
-
The National Institute for Occupational Safety and Health (NIOSH) is considering a revision to its glutaraldehyde recommended exposure limit (REL) and has issued a Federal Register notice asking for information on glutaraldehyde research, use, safety training, and manufacture (edocket.access.gpo.gov/2009/E9-22299.htm).
-
Do you think surgical fires happen a lot less often than wrong-site surgery or retained instruments? Think again.
-
In next month's issue of Same-Day Surgery, we'll include our annual special focus on cost savings.
-
A mindfulness-based stress reduction intervention, shortened so it could be done in the workplace, was done on healthy employees for a six-week period, with researchers measuring salivary cortisol each week.
-
Recognizing that more than half the population with depression is treated in the primary care setting, MercyCare Health Plans developed a depression disease management program focusing on giving primary care physicians the tools they need to be able to recognize and treat depression.